Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26145 | 216 | 27.8 | 48% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1105 | 9279 | BEERS CRITERIA//PHARMACOVIGILANCE//MEDICATION RECONCILIATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BOUCICAUT | Address | 1 | 100% | 1% | 2 |
| 2 | COVERT MEDICATION | Author keyword | 1 | 100% | 1% | 2 |
| 3 | CRUSHED DRUGS | Author keyword | 1 | 50% | 1% | 2 |
| 4 | GALENIC FORM | Author keyword | 1 | 50% | 1% | 2 |
| 5 | SERV SOINS INTERDISCIPLINAIRE PATIENT ONCOL | Address | 1 | 100% | 1% | 2 |
| 6 | ENTERAL FEEDING TUBE | Author keyword | 1 | 27% | 1% | 3 |
| 7 | ARGUMENT BASED ETHICS | Author keyword | 1 | 50% | 0% | 1 |
| 8 | CAPSULE OPENING | Author keyword | 1 | 50% | 0% | 1 |
| 9 | CRUSHED | Author keyword | 1 | 50% | 0% | 1 |
| 10 | DISCIPLINA FUNDAMENTOS GERONTOL | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | COVERT MEDICATION | 1 | 100% | 1% | 2 | Search COVERT+MEDICATION | Search COVERT+MEDICATION |
| 2 | CRUSHED DRUGS | 1 | 50% | 1% | 2 | Search CRUSHED+DRUGS | Search CRUSHED+DRUGS |
| 3 | GALENIC FORM | 1 | 50% | 1% | 2 | Search GALENIC+FORM | Search GALENIC+FORM |
| 4 | ENTERAL FEEDING TUBE | 1 | 27% | 1% | 3 | Search ENTERAL+FEEDING+TUBE | Search ENTERAL+FEEDING+TUBE |
| 5 | ARGUMENT BASED ETHICS | 1 | 50% | 0% | 1 | Search ARGUMENT+BASED+ETHICS | Search ARGUMENT+BASED+ETHICS |
| 6 | CAPSULE OPENING | 1 | 50% | 0% | 1 | Search CAPSULE+OPENING | Search CAPSULE+OPENING |
| 7 | CRUSHED | 1 | 50% | 0% | 1 | Search CRUSHED | Search CRUSHED |
| 8 | DRUG NUTRITION INTERACTION | 1 | 50% | 0% | 1 | Search DRUG+NUTRITION+INTERACTION | Search DRUG+NUTRITION+INTERACTION |
| 9 | ENTERAL TUBES | 1 | 50% | 0% | 1 | Search ENTERAL+TUBES | Search ENTERAL+TUBES |
| 10 | EXTENDED RELEASE CAPSULE | 1 | 50% | 0% | 1 | Search EXTENDED+RELEASE+CAPSULE | Search EXTENDED+RELEASE+CAPSULE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | COVERT MEDICATION | 9 | 83% | 2% | 5 |
| 2 | NUTRIENT INTERACTIONS | 6 | 44% | 5% | 11 |
| 3 | NASOGASTRIC FEEDINGS | 4 | 67% | 2% | 4 |
| 4 | NUTRIENT FORMULA | 4 | 75% | 1% | 3 |
| 5 | ORAL PHENYTOIN | 4 | 41% | 3% | 7 |
| 6 | CIPROFLOXACIN ABSORPTION | 1 | 100% | 1% | 2 |
| 7 | ENTERAL NUTRIENT FORMULA | 1 | 100% | 1% | 2 |
| 8 | NUTRIENT FORMULAS | 1 | 100% | 1% | 2 |
| 9 | ENTERAL FEEDING TUBES | 1 | 29% | 2% | 4 |
| 10 | CARBAMAZEPINE SUSPENSION | 1 | 40% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Covert administration of medication to older adults: a review of the literature and published studies | 2010 | 3 | 14 | 86% |
| Interactions between drugs and drug-nutrient in enteral nutrition: A review based on evidences | 2014 | 0 | 1 | 100% |
| Dose form modification - a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatients | 2008 | 18 | 9 | 56% |
| Enteral nutrition: Drug administration via feeding tube | 2005 | 3 | 23 | 61% |
| DRUG-NUTRIENT INTERACTIONS | 1995 | 24 | 27 | 41% |
| Impact of direct drug delivery via gastric access devices | 2015 | 0 | 57 | 32% |
| Therapeutic concerns when oral medications are administered nasogastrically | 2013 | 3 | 31 | 13% |
| Alternative Formulations, Delivery Methods, and Administration Options for Psychotropic Medications in Elderly Patients With Behavioral and Psychological Symptoms of Dementia | 2010 | 6 | 49 | 14% |
| Important drug-nutrient interactions in the elderly | 1998 | 11 | 42 | 24% |
| A systematic review of nursing administration of medication via enteral tubes in adults | 2008 | 9 | 12 | 17% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BOUCICAUT | 1 | 100% | 0.9% | 2 |
| 2 | SERV SOINS INTERDISCIPLINAIRE PATIENT ONCOL | 1 | 100% | 0.9% | 2 |
| 3 | DISCIPLINA FUNDAMENTOS GERONTOL | 1 | 50% | 0.5% | 1 |
| 4 | INFORMACOES MEDICAMENTOS | 1 | 50% | 0.5% | 1 |
| 5 | MED TOXICOL FELLOWSHIP | 1 | 50% | 0.5% | 1 |
| 6 | NORMAN REG HLTH SYST | 1 | 50% | 0.5% | 1 |
| 7 | SERV DIABETOL MALADIES METABOL NUTR | 1 | 50% | 0.5% | 1 |
| 8 | SOINS SUITE READ TAT | 1 | 50% | 0.5% | 1 |
| 9 | ONCOL PALLIAT CARE UNIT | 0 | 33% | 0.5% | 1 |
| 10 | COOPERAT UNIT CLIN PHARM | 0 | 10% | 1.4% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000227171 | TABLET SPLITTING//SCORED TABLETS//SCORE LINE |
| 2 | 0.0000173194 | ENTERAL TUBE FEEDS//ENTERAL FEEDS//ENTERAL FEEDING SYSTEMS |
| 3 | 0.0000087482 | VITAMIN NUTRITURE//VITAMIN STATUS//DISEASED ELDERLY |
| 4 | 0.0000087000 | MICROSOMAL FATTY ACID COMPOSITION//CYTOCHROME P 4501A2//CYTOCHROME P 4501A1 |
| 5 | 0.0000086981 | CARBAMAZEPINE 10 11 EPOXIDE//FREE PHENYTOIN//R 4PK |
| 6 | 0.0000083666 | GLIBORNURIDE//MALMO GEN HOSP ENDOCRINOL//ALCOHOL TOLERANCE |
| 7 | 0.0000075035 | GRAPEFRUIT JUICE//HERB DRUG INTERACTIONS//BERGAMOTTIN |
| 8 | 0.0000074407 | POTENTIAL DRUG DRUG INTERACTION//POTENTIAL DRUG DRUG INTERACTIONS//PRESCRIPTIONS SCREENING |
| 9 | 0.0000066930 | PROD FORMULAT YODOGAWA KU//CHLORPHENESIN CARBAMATE//DISSOLUTION HEAT |
| 10 | 0.0000065709 | INTERACTION WITH CALF THYMUS DNA//COMPETITIVE STUDIES WITH ETHIDIUM BROMIDE//NORFLOXACIN |